DASH-Obesity: Explainable AI for Family-Centric Personalized Weight Control in Adolescents and Young Adults With Obesity and Chronic Conditions

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAdhera Health, Inc.

About this trial

This prospective single-arm feasibility study evaluates the Adhera Caring Digital Program for Obesity (ACDP-O), a family-centered digital health intervention designed to support adolescents and young adults with overweight/obesity and chronic conditions, including type 1 diabetes (T1D) and asthma. The intervention combines personalized educational content, wearable-device monitoring, psychometric assessments, and explainable artificial intelligence (AI) to improve mental well-being, quality of life, and adherence to healthy lifestyle behaviors. A total of 280 families will participate in a 3-month intervention with remote monitoring and follow-up assessments.

Eligibility criteria

Qualifiers

Adult caregiver (aged 18 years or older) of an adolescent or young adult aged 12 to 21 years diagnosed with Type 1 Diabetes (T1D) or asthma.

The caregiver is actively involved in the management of the adolescent's or young adult's condition.

T1D and normal weight (BMI between the 10th and 85th percentile), or

T1D and overweight/obesity (BMI ≥85th percentile), or

Disqualifiers

Severe psychiatric or cognitive conditions that would interfere with participation in the digital intervention.

Current participation in another obesity- or chronic disease-related digital health intervention study.

Inability or unwillingness to comply with study procedures.

Refusal or inability to provide informed consent.

Trial design

Treatments tested in this trial

  • Adhera Caring Digital Program-Obesity (ACDP-O)

Treatment groups

280 Participants
are divided into 1 treatment group

Sponsors and collaborators